Off-label prescription of tigecycline: clinical and microbiological characteristics and outcomes
Authors:
- David Conde-EstévezDCDavid Conde-Estévez
- Santiago GrauSGSantiago Grau
- Juan Pablo HorcajadaJuan Pablo Horcajada
- Sonia LuqueSLSonia Luque
- 1 November 2010
- journal article
- other
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 36 (5) , 471-472
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Off-label use of antibiotics in hospitalized patients: focus on tigecyclineJournal of Antimicrobial Chemotherapy, 2009
- Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registryThe Brazilian Journal of Infectious Diseases, 2008
- A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]BMC Infectious Diseases, 2005
- The Efficacy and Safety of Tigecycline in the Treatment of Skin and Skin‐Structure Infections: Results of 2 Double‐Blind Phase 3 Comparison Studies with Vancomycin‐AztreonamClinical Infectious Diseases, 2005
- TigecyclineJournal of Antimicrobial Chemotherapy, 2005
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993